When was Shanghai B&C Pharmaceutical founded?

Shanghai B&C Pharmaceutical was founded in 2010 and became a unicorn in 2023, reaching the milestone in 13 years. It raised its 1st funding round 11 years after its incorporation.

Where is Shanghai B&C Pharmaceutical located?

Shanghai B&C Pharmaceutical is headquartered in Xuzhou, China.

How many employees does Shanghai B&C Pharmaceutical have?

As of Apr 30, 2026, the latest employee count at Shanghai B&C Pharmaceutical is 6.

Is Shanghai B&C Pharmaceutical a funded company?

Shanghai B&C Pharmaceutical is a funded company, having raised a total of $131M across 5 funding rounds to date. The company's 1st funding round was a $43.5M Series C round, raised on Aug 2021.

How much is Shanghai B&C Pharmaceutical worth?

The latest valuation of Shanghai B&C Pharmaceutical is $1B as of Apr 24, 2023.

When was the latest funding round of Shanghai B&C Pharmaceutical?

Shanghai B&C Pharmaceutical's latest funding was a $87M Series C round on Apr 24, 2023, with participation from 7 investors.

Is Shanghai B&C Pharmaceutical a Advanced Materials company?

The primary sector of Shanghai B&C Pharmaceutical is Advanced Materials.

Where does Shanghai B&C Pharmaceutical rank among its competitors?

Shanghai B&C Pharmaceutical ranks 2nd amongst 4 active competitors, only 1 of which is funded. Polymerolutions.com, which secured $275K in May, 2023.

Who are the top competitors of Shanghai B&C Pharmaceutical?

Shanghai B&C Pharmaceutical's top competitors include Inpria, Polymerolutions.com and Jiangsu Boyan Electronic Technology. Among them, Polymerolutions.com secured the most recent funding round in May, 2023.

Shanghai B&C Pharmaceutical - 2026 Company Profile, Team, Funding & Competitors

Shanghai B&C Pharmaceutical is a series C company based in Xuzhou (China), founded in 2010 by Fu Zhiwei. It operates as a Manufacturer of photoresists and related raw materials. Shanghai B&C Pharmaceutical has raised $131M in funding from Zhongping Capital and Guokai Technology Venture Investment, with a current valuation of $1B. The company has 4 active competitors, including 1 funded and 1 that has exited. Its top competitors are Inpria, Polymerolutions.com and Jiangsu Boyan Electronic Technology.

Sectors and market segments that Shanghai B&C Pharmaceutical operate in

Shanghai B&C Pharmaceutical serves in the High Tech, Chemicals and Materials Tech market segments.The primary business model of Shanghai B&C Pharmaceutical are:

Company Details

Manufacturer of photoresists and related raw materials. It provides users with a platform for manufacturing photoresists for the semiconductor industry. Its product portfolio includes photoresists, photoresist monomers, photoresist resins, and other chemicals for industrial clients.

Website: www.bcpharma.com
Phone Number: +86 **********

Key Metrics

Founded Year

2010

Location

Xuzhou, China

Stage

Series C

Total Funding

$131M in 5 rounds

Latest Funding Round

Series C, Apr 24, 2023, $87M

Post Money Valuation

$1B as on Apr 24, 2023

Investors

Zhongping Capital & 11 more

Ranked

2^nd among 4 active competitors

Employee Count

6 as on Apr 30, 2026

Similar Companies

Inpria & 2 more

View Shanghai B&C Pharmaceutical's full profile

Shanghai B&C Pharmaceutical has raised a total funding of $131M over 5 rounds. Its first funding round was on Aug 2021. Its latest funding round was a Series C round on Apr 24, 2023 for $87M. 7 investors participated in its latest round. Shanghai B&C Pharmaceutical has 12 institutional investors.

Here is the list of recent funding rounds of Shanghai B&C Pharmaceutical:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 24, 2023	$87M	Series C	$1B	-	Zhongping Capital, Guokai Technology Venture Investment	NEW HOPE CAPITAL, V Fund, Qingsong Fund, Suzhou Guofa Venture Capital Holdings, Sdrailfund
2022	Undisclosed	Series C	-	-	-	-
2022	Undisclosed	Series C	-	-	-	CGP Investment, Xinding Capital, NEW HOPE CAPITAL

Access funding benchmarks and valuations. Sign up today!

View details of Shanghai B&C Pharmaceutical's funding rounds and investors

The founders of Shanghai B&C Pharmaceutical is Fu Zhiwei.

Here are the details of Shanghai B&C Pharmaceutical's key team members:

Fu Zhiwei: Founder of Shanghai B&C Pharmaceutical.

View details of Shanghai B&C Pharmaceutical's Founder profiles and Board Members

Shanghai B&C Pharmaceutical's employee count trend

Shanghai B&C Pharmaceutical has 6 employees as of Apr 26. Here is Shanghai B&C Pharmaceutical's employee count trend over the years:

Employee count trend for Shanghai B&C Pharmaceutical

Uncover Shanghai B&C Pharmaceutical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Shanghai B&C Pharmaceutical include Inpria, Polymerolutions.com and Jiangsu Boyan Electronic Technology. Here is the list of Top 10 competitors of Shanghai B&C Pharmaceutical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Inpria 2007, Corvallis (United States), Acquired	Provider of photoresists and other thin films	$68.8M	Samsung Venture Investment, JSR Corporation ... & 12 others	53/100
2nd	Shanghai B&C Pharmaceutical 2010, Xuzhou (China), Series C	Manufacturer of photoresists and related raw materials	$131M	Xinding Capital, Huawei & 10 others	42/100
3rd	Polymerolutions.com Funding Raised	Manufacturer of polyphthalaldehyde-based plastics for direct write patterning technologies	-	National Science Foundation	15/100
4th	Jiangsu Boyan Electronic Technology 2014, Wuxi (China), Funding Raised	Manufacturer of photoresist products	-	Chentao Capital	15/100